Carla Loreto Selected Research

fluor-edenite

1/2022	Dysregulation of microRNAs and tRNA-derived ncRNAs in mesothelial and mesothelioma cell lines after asbestiform fiber exposure.
12/2021	ATG7 immunohistochemical expression in malignant pleural mesothelioma. A preliminary report.
1/2021	Immunohistochemical Expression of Serine and Arginine-Rich Splicing Factor 1 (SRSF1) in Fluoro-Edenite-Induced Malignant Mesothelioma: A Preliminary Study.
4/2020	Defense and protection mechanisms in lung exposed to asbestiform fiber: the role of macrophage migration inhibitory factor and heme oxygenase-1.
1/2020	An In vivo Immunohistochemical Study on MacroH2A.1 in Lung and Lymph-Node Tissues Exposed to an Asbestiform Fiber.
3/2018	Fibulin-3 immunoexpression in malignant mesothelioma due to fluoro-edenite: a preliminary report.
3/2018	Occupational exposure to fluoro-edenite and prevalence of anti-nuclear autoantibodies.
2/2018	Immunohistochemical Expression of Aquaporin-1 in Fluoro-Edenite-Induced Malignant Mesothelioma: A Preliminary Report.
1/2017	Analysis of fibulin-3 after exposure to asbestos-like fibers.
11/2016	Fluoro-edenite induces fibulin-3 overexpression in non-malignant human mesothelial cells.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Carla Loreto Research Topics

Disease

12	Neoplasms (Cancer) 01/2022 - 06/2011
11	Malignant Mesothelioma 01/2022 - 01/2015
6	Osteoarthritis 01/2018 - 11/2011
5	Mesothelioma 01/2022 - 01/2016
5	Inflammation (Inflammations) 01/2020 - 07/2013
4	Cognitive Dysfunction 01/2017 - 03/2013
3	Fibrosis (Cirrhosis) 04/2020 - 07/2012
3	Lung Neoplasms (Lung Cancer) 01/2020 - 06/2011
3	Lung Diseases (Lung Disease) 01/2020 - 06/2011
3	Alzheimer Disease (Alzheimer's Disease) 08/2019 - 03/2014
3	Memory Disorders (Memory Loss) 10/2015 - 03/2013
3	Pathologic Processes 08/2015 - 03/2013
3	Carcinoma (Carcinomatosis) 01/2014 - 02/2009
3	Erectile Dysfunction 09/2012 - 01/2012
3	Penile Induration (Peyronie's Disease) 09/2012 - 01/2011
2	Type 2 Diabetes Mellitus (MODY) 12/2020 - 05/2016
2	Carcinogenesis 01/2020 - 08/2015
2	Skin Diseases (Skin Disease) 10/2019 - 09/2007
2	Neoplasm Metastasis (Metastasis) 10/2014 - 12/2013
2	B-Cell Lymphoma (Lymphoma, B Cell) 03/2014 - 05/2013
2	Melanoma (Melanoma, Malignant) 10/2013 - 07/2009
2	Osteoporosis 05/2013 - 01/2013
2	Retinoblastoma (Glioblastoma, Retinal) 06/2011 - 06/2010
2	Intervertebral Disc Degeneration 03/2011 - 03/2011
1	Postoperative Pain 04/2022
1	Endometriosis 04/2022
1	Pelvic Organ Prolapse 04/2022
1	Respiratory Tract Diseases (Respiratory Tract Disease) 01/2022
1	Basal Cell Nevus Syndrome (Gorlin Syndrome) 01/2022
1	Odontogenic Cysts (Keratocyst) 01/2022
1	Asthma (Bronchial Asthma) 01/2021
1	Hypersensitivity (Allergy) 01/2021
1	Albuminuria 12/2020
1	Chronic Renal Insufficiency 12/2020
1	Pleural Diseases 04/2020
1	Urinary Incontinence 11/2019
1	Urethral Stricture 11/2019
1	Pathologic Constriction (Stenosis) 11/2019
1	Dementia (Dementias) 08/2019
1	Neuroinflammatory Diseases 08/2019
1	Mental Fatigue 01/2019
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 01/2019
1	Fatigue 01/2019
1	Temporomandibular Joint Disorders (Temporomandibular Joint Disorder) 07/2018
1	Prostatic Neoplasms (Prostate Cancer) 01/2018
1	Hepatitis B 02/2017
1	Diabetes Mellitus 02/2017

Drug/Important Bio-Agent (IBA)

14	fluor-edeniteIBA 01/2022 - 06/2010
6	AsbestosIBA 12/2021 - 06/2011
5	Biomarkers (Surrogate Marker)IBA 07/2020 - 01/2015
5	lubricinIBA 06/2014 - 11/2011
4	Proteins (Proteins, Gene)FDA Link 06/2014 - 06/2011
3	Matrix Metalloproteinases (MMPs)IBA 01/2022 - 03/2011
3	MicroRNAs (MicroRNA)IBA 01/2022 - 07/2020
3	CytokinesIBA 01/2020 - 12/2013
3	Mineral Fibers (Mineral Fiber)IBA 03/2018 - 02/2009
3	Olive OilIBA 01/2018 - 12/2013
3	Amphibole AsbestosIBA 01/2017 - 01/2016
3	Caspase 3 (Caspase-3)IBA 01/2017 - 07/2013
2	Arginine (L-Arginine)FDA Link 01/2021 - 10/2011
2	Amyloid (Amyloid Fibrils)IBA 08/2019 - 01/2015
2	Indicators and Reagents (Reagents)IBA 02/2018 - 10/2014
2	AflatoxinsIBA 02/2017 - 05/2016
2	Glycoproteins (Glycoprotein)IBA 01/2017 - 11/2011
2	Serotonin (5 Hydroxytryptamine)IBA 01/2017 - 10/2015
2	Brain-Derived Neurotrophic Factor (BDNF)IBA 10/2015 - 03/2014
2	Phosphatidylethanolamine Binding ProteinIBA 10/2014 - 10/2013
2	Type 5 Cyclic Nucleotide PhosphodiesterasesIBA 03/2014 - 03/2013
2	Biological ProductsIBA 07/2013 - 06/2011
2	GlucocorticoidsIBA 05/2013 - 01/2013
2	Prednisolone (Predate)FDA LinkGeneric 05/2013 - 01/2013
2	Retinoblastoma ProteinIBA 06/2011 - 06/2010
2	LigandsIBA 03/2011 - 01/2011
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2011 - 01/2011
2	asphaltIBA 07/2009 - 09/2007
1	Hemoglobins (Hemoglobin)IBA 04/2022
1	Calmodulin-Binding Proteins (Caldesmon)IBA 01/2022
1	DesminIBA 01/2022
1	Transfer RNA (tRNA)IBA 01/2022
1	Untranslated RNA (Noncoding RNA)IBA 01/2022
1	Serine (L-Serine)FDA Link 01/2021
1	RNA Splicing FactorsIBA 01/2021
1	Hypoglycemic Agents (Hypoglycemics)IBA 12/2020
1	LipidsIBA 12/2020
1	NitritesIBA 01/2020
1	macroH2A histoneIBA 01/2020
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2020
1	Protein Isoforms (Isoforms)IBA 01/2020
1	Oxygen (Dioxygen)IBA 01/2020
1	Pharmaceutical PreparationsIBA 01/2019
1	Interleukin-1 (Interleukin 1)IBA 07/2018
1	CadmiumIBA 01/2018
1	Oral ContraceptivesIBA 02/2017

Therapy/Procedure

2	Therapeutics 10/2014 - 12/2013
2	Penile Prosthesis (Penile Implants) 07/2012 - 01/2012
2	Penile Implantation 07/2012 - 01/2012
1	Uterine Myomectomy 04/2022
1	Hysterectomy 04/2022
1	Oral Administration 01/2021
1	Transurethral Resection of Prostate (TURP) 11/2019